EA
MED icon

Emerald Acquisition’s Medifast MED Stock Holding History

Emerald Acquisition’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$2.68M Buy
70,884
+20,164
+40% +$723K 0.01% 1586
2016
Q2 		$1.69M Buy
+50,720
New +$1.64M ﹤0.01% 1920

Other funds holding MED

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Emerald Acquisition's MED Position: Q3 2016 in Review

Emerald Acquisition increased its Medifast (MED) stake by 40% in Q3 2016, buying an estimated $723K and bringing the position to 70,884 shares worth $2.68M. The position accounts for 0.01% of the portfolio, ranked #1586.

Emerald Acquisition first reported a position in MED in Q2 2016 and has held it in 2 quarters since. 165 funds tracked by Wall St. Rank hold MED as of Q3 2016.

  • Emerald Acquisition held 70,884 shares of Medifast worth $2.68M as of Q3 2016.
  • Emerald Acquisition bought 20,164 Medifast shares in Q3 2016, an estimated $723K.
  • Medifast made up 0.01% of Emerald Acquisition's portfolio in Q3 2016, its #1586 holding.
  • Emerald Acquisition first reported a position in Medifast in Q2 2016 and has held it in 2 quarters since.
  • 165 funds tracked by Wall St. Rank held Medifast as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.